CytomX Therapeutics, Inc. short interest in 2018
In 2018, CytomX Therapeutics, Inc.'s disclosed short interest ran from 3.02% of shares outstanding on 12 Jan 2018 to 5.30% on 31 Dec 2018, a change of +2.28 percentage points. The year's high was 7.29% on 29 Jun 2018 and its low 2.42% on 31 Jan 2018, averaging 4.59% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.96 days on 31 Aug 2018. Full history: CytomX Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2018 in figures
- Start of year
- 3.02% (12 Jan 2018)
- End of year
- 5.30% (31 Dec 2018)
- Change
- +2.28 pp
- High
- 7.29% (29 Jun 2018)
- Low
- 2.42% (31 Jan 2018)
- Average
- 4.59%
- Highest days to cover
- 9.96 (31 Aug 2018)
- SEC filings marked
- 9
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 3.02% | 2.91 | |
| 31 Jan 2018 | 2.42% | 3.18 | |
| 15 Feb 2018 | 2.61% | 3.35 | |
| 28 Feb 2018 | 2.87% | 3.96 | |
| 15 Mar 2018 | 3.09% | 2.05 | 10-K filed, results (8-K) |
| 29 Mar 2018 | 2.66% | 2.41 | |
| 13 Apr 2018 | 2.70% | 3.45 | |
| 30 Apr 2018 | 2.68% | 3.54 | |
| 15 May 2018 | 3.57% | 3.82 | 10-Q filed, results (8-K) |
| 31 May 2018 | 4.53% | 5.42 | |
| 15 Jun 2018 | 5.32% | 3.13 | |
| 29 Jun 2018 | 7.29% | 5.73 | |
| 13 Jul 2018 | 7.00% | 5.03 | results (8-K) |
| 31 Jul 2018 | 5.59% | 3.96 | |
| 15 Aug 2018 | 5.35% | 7.32 | 10-Q filed, results (8-K) |
| 31 Aug 2018 | 5.38% | 9.96 | |
| 14 Sep 2018 | 5.03% | 4.77 | |
| 28 Sep 2018 | 6.20% | 7.25 | |
| 15 Oct 2018 | 6.00% | 7.51 | |
| 31 Oct 2018 | 5.84% | 7.38 | |
| 15 Nov 2018 | 5.55% | 4.74 | 10-Q filed, results (8-K) |
| 30 Nov 2018 | 4.92% | 7.10 | |
| 14 Dec 2018 | 5.18% | 4.67 | |
| 31 Dec 2018 | 5.30% | 4.46 |
See also: CytomX Therapeutics, Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.